Search clinical trials for: Etanerept

Total 423 results

Sun Yat-sen University

Completed

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Spondyloarthritis

China
Pfizer

Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Korea, Republic of
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

Psoriasis
EMS

Withdrawn

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Brazil
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain (Loadet)

Ankylosing Spondylitis
LG Life Sciences

Completed

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Healthy

Korea, Republic of
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis

Ankylosing Spondylitis

China
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd

Unknown

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

Psoriasis | Plaque Psoriasis

China
Amgen

Completed

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Arthritis, Rheumatoid; Arthritis, Psoriatic

United States, Puerto Rico
mAbxience Research S.L.

Recruiting

A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders (MB04-A-01-23)

Healthy Volunteers

Netherlands
Sun Yat-sen University

Completed

A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis

Spondyloarthropathy

China
Amgen

Completed

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

Rheumatoid Arthritis | Plaque Psoriasis

United States, Canada
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Poland, United Kingdom
Amgen

Completed

Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects

Healthy Men and Women
Amgen

Completed

Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection

Healthy Men and Women
Sun Pharmaceutical Industries Limited

Withdrawn

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Plaque-type Psoriasis
University Hospital, Gentofte, Copenhagen
Pfizer; The Michaelsen Foundation

Unknown

TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

Psoriasis

Denmark, Sweden
Palleon Pharmaceuticals, Inc.

Recruiting

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (GLIMMER-01)

Melanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJ

United States
Pfizer

Completed

Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept (ReSPONSE)

Psoriasis

Spain, France, Germany, Turkey, United Kingdom, Hungary, Greece, Italy, United Arab Emirates
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Etanercept in the Treatment of Psoriasis in Adult Subjects

Inflammation | Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Sun Pharmaceutical Industries Limited

Completed

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) (reSURFACE 2)

Plaque Psoriasis
Sun Yat-sen University

Completed

Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis

Ankylosing Spondylitis

China
Pfizer

Completed

Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects

Arthritis, Rheumatoid

Greece, Germany, Hungary, South Africa, Poland, Bulgaria, Croatia, Serbia, Slovakia
Medical University of Warsaw

Completed

Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function

Transplanted Kidney Ischemia Reperfusion Injury

Poland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

Plaque Psoriasis | Nail Psoriasis
Pfizer

Completed

An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial (RELOADET)

Ankylosing Spondylitis

Spain
Pfizer
Innovex, Inc

Completed

Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

Rheumatoid Arthritis

Luxembourg
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
Pfizer

Completed

Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice (REACH RA)

Rheumatoid Arthritis

Belgium
Pfizer

Completed

Defining Remission With Etanercept in AS in Real Life Clinical Practice (REACH AS)

Ankylosing Spondylitis

Belgium
Penn State University
Amgen

Completed

Treatment of Hidradenitis Suppurativa Using Etanercept

Hidradenitis Suppurativa

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

Anorexia | Unspecified Adult Solid Tumor, Protocol Specific | Cachexia

United States
Florida Academic Dermatology Centers
Amgen

Unknown

An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use (ENBRECAP2009)

Psoriasis

United States
Pfizer
Lincoln Medical and Mental Health Center

Terminated

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients (CREST)

Ankylosing Spondylitis

Italy
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

United States
Assistance Publique Hopitaux De Marseille

Completed

Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?

Rheumatoid Arthritis | Psoriatic Arthritis | Inflammatory Rheumatism

France
Massachusetts General Hospital
Brigham and Women's Hospital; Stanford University

Completed

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Pemphigus Vulgaris

United States
Pfizer

Completed

Observational Trial With Enbrel

Rheumatoid Arthritis

Germany
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Psoriasis | Skin Diseases, Papulosquamous | Arthritis, Psoriatic

Germany
Amgen

Completed

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

Psoriatic Arthritis

France, Belgium, Korea, Republic of, Netherlands, United Kingdom, Germany, Taiwan, Portugal, Denmark, Saudi Arabia, Czechia, Sweden, Switzerland, Argentina, Poland, Italy, Hungary, Spain, Australia, Austria, Colombia, Finland, Former... and more
Dermatrials Research
Amgen

Completed

The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

Plaque Psoriasis

Canada
University of Wisconsin, Madison
Immunex Corporation

Completed

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

HIV Infections

United States
University of Pennsylvania

Completed

Etanercept for Treatment of Hidradenitis

Hidradenitis Suppurativa
University of Alabama at Birmingham
Amgen

Completed

Can We Miss Pigmented Lesions in Psoriasis Patients?

Melanoma | Psoriasis | Non-melanoma Skin Cancer

United States
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Psoriasis
National Institute of Dental and Craniofacial Research...

Completed

Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction

Inflammation | Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

3

Subscribe